• Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
• Legislative proposals impacting the prescription drug industry including H.R. 3
• Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals and H.R. 3.
• Issues relating to tax provisions covering the pharmaceutical industry. Ongoing monitoring of the consideration of the American Jobs Plan.

Duration: January 1, 2008 to December 31, 2021

General Issues: Trade (Domestic & Foreign), Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations, Veterans, Financial Institutions/Investments/Securities

Spending: about $1,667,500 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Commerce - Dept of (DOC), U.S. Trade Representative (USTR), U.S. Senate,, Internal Revenue Service (IRS)